Why RTW Biotech Opportunities merger with Arix Bioscience is good for shareholders
RTW Biotech Opportunities (RTW) $1.11Loss to date: 16.5%We highlighted RTW Biotech Opportunities(RTW) at $1.33 in July for its superior trackrecord which was not reflected in the shares trading at an unwarranted 23% discount to NAV (net asset value).WHAT HAS HAPPENED SINCE WE SAID TO BUY?Sentiment in the biotechnology sector remains depressed with the Nasdaq Biotechnology index dropping around...